Marijuana public health has long been a battleground between science and public opinion. For years, researchers and clinicians raised serious concerns, yet influential voices in the American media largely dismissed them. A landmark editorial from the New York Times signals that the tide is turning. The paper now openly acknowledges that cannabis harm and legalisation have produced outcomes far worse than most people expected.

Marijuana Public Health: A Paper That Once Cheered Legalisation Sounds the Alarm

The New York Times historically supported marijuana legalisation. That makes its latest editorial so striking. The board now concedes that loosening marijuana laws produced outcomes worse than many anticipated. Readers who followed the paper’s traditionally permissive line will find this conclusion surprising.

The editorial pointed to the drug’s serious addictive potential and its links to mental health disorders. Around 18 million Americans now use marijuana almost daily. Hospitals across the country report rising numbers of patients with cannabis-linked paranoia and chronic psychotic conditions. These are not fringe findings. Years of accumulating evidence on cannabis harm and legalisation policy back them up.

The Science Has Long Warned Us About Cannabis Harm and Legalisation

Researchers raised the alarm about marijuana public health consequences for well over a decade. The problem was never a lack of data. The problem was a lack of willingness to take that data seriously in public discourse.

That picture is changing fast. Last September, the American College of Obstetricians and Gynaecologists issued a clinical consensus supporting marijuana screening during pregnancy. It warned explicitly about the drug’s dangers to foetal development. Two months later, the Journal of the American Medical Association published a sweeping review of randomised clinical trials. The review concluded that evidence does not support cannabis or cannabinoids for most conditions it is promoted for, including acute pain and insomnia.

Research from Columbia University and the University of California documents the broader marijuana public health impact. One major study linked cannabis use to as much as 30 per cent of schizophrenia cases among young men. Separate findings connect the drug with significantly higher risks of heart attack and diabetes. The Wall Street Journal also highlighted alarming data linking marijuana use among young people to severe psychiatric disorders.

These are peer-reviewed findings from respected medical journals. They paint a troubling picture of what happens when cannabis harm and legalisation move ahead without adequate safeguards.

Public Opinion on Marijuana Public Health Is Shifting Fast

Scientists and medical bodies are not the only ones growing more cautious. Ordinary people are reassessing their views too.

Gallup polling shows public support for legal marijuana falling sharply from its 2023 peak, now trending downward across the electorate. Among Republicans, the retreat has been particularly sharp. Support dropped from 55 per cent at its high point to just 40 per cent in 2025. That 15-point collapse reflects something real: a growing public recognition that the costs of marijuana legalisation were badly underestimated.

This shift in public sentiment helps explain why no US state has voted to legalise marijuana in the past two election cycles. Efforts to reverse existing legalisation are now gaining real momentum. In Massachusetts, one such measure is advancing steadily towards the ballot this November.

Change is visible even inside the Times itself. Columnist Ezra Klein, long associated with progressive drug policy positions, now publicly reassesses the case for permissive marijuana laws. When writers at the paper that once championed legalisation start asking harder questions, a broader cultural rethink is clearly underway.

Why This Moment Matters

Commercial interests, cultural libertarianism, and a fear of appearing reactionary dominated the marijuana public health debate for too long. Those who raised concerns often faced dismissal as moralists. The evidence sat on the margins.

The New York Times editorial changes that dynamic. It gives credibility to a position the data has supported for years. The paper still supports regulated legalisation over prohibition, but its acknowledgement that the current trajectory causes real harm carries weight. Politicians, clinicians, and commentators who have quietly harboured these concerns now have more room to speak plainly.

The consequences of cannabis harm and legalisation in practice have been significant. A commercial industry with powerful financial incentives to downplay risk expanded rapidly. A drug with genuine addictive potential became normalised among teenagers and young adults. Meanwhile, a generation grew up hearing that marijuana was essentially harmless, even as the evidence told a very different story.

The New York Times now joins medical associations, academic researchers, and a sceptical public in saying the reckoning on marijuana can no longer wait.

Source: unherd